Coronavirus: Experimental COVID-19 drug fails in human beings

0
115

As the quest for vaccines continues, experimental coronavirus treatment remdesivir has failed in its first randomised clinical trial

Results of the trial were released on Thursday, April 23, dashing all hopes

The deadly disease was first recorded in China in December 2019

The experimental coronavirus treatment remdesivir has failed in its first randomised clinical trial.

Results of the trial were released on Thursday, April 23, Manila Bulletin reports.

READ ALSO:Trump claims heat kills virus, tells Americans to ‘enjoy the sun’

According to a draft summary that went online briefly on the website of the World Health Organization (WHO), the Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group. Remdesivir was stopped early in 18 patients because of side effects.

After three months, 13.9 percent of the patients on remdesivir had succumbed to the deadly disease compared to 12.8 percent of those in the control group. The difference is not statistically significant.

The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.

Coronavirus: Experimental COVID-19 drug fails in human beings

A vial of Remdesivir

Watch Leakblast TV channel from around the world

Thanks for Reading via the most updated news portal

About Leakblast.com

Share your story with us

Advertise With us

Encourage & Support LeakBlast

Feel free to contact us

Call Us:+234(0)9073726403
Get us on Whatsapp: +234(0)8181166425      
Email Us: editors@leakblast.com

 

SUPPORT LEAKBLAST JOURNALISM OF INTEGRITY AND CREDIBILITY

Good  journalism costs a lot of money.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble Endeavor.

By contributing to LeakBlast, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Support LeakBlast

LEAVE A REPLY

Please enter your comment!
Please enter your name here